Lipid–drug conjugates and associated carrier strategies for enhanced antiretroviral drug delivery-Reference-Cited by-同舟云学术

Lipid–drug conjugates and associated carrier strategies for enhanced antiretroviral drug delivery

Published:2019-12-20 Issue:3 Volume:25 Page:267-280
ISSN:1083-7450
Container-title:Pharmaceutical Development and Technology
language:en
Short-container-title:Pharmaceutical Development and Technology

Author:

Takalani Funanani¹,Kumar Pradeep¹^ORCID,Kondiah Pierre P. D.¹^ORCID,Choonara Yahya E.¹^ORCID,Pillay Viness¹^ORCID

Affiliation:

1. Wits Advanced Drug Delivery Platform Research Unit, Department of Pharmacy and Pharmacology, School of Therapeutic Sciences, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa

Publisher

Informa UK Limited

Subject

Pharmaceutical Science,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/10837450.2019.1694037

Reference78 articles.

1. Nano lipid-drug conjugate: An integrated review

2. Emtricitabine Prodrugs with Improved Anti-HIV Activity and Cellular Uptake

3. Synthesis and Biological Evaluation of Fatty Acyl Ester Derivatives of (−)-2′,3′-Dideoxy-3′-thiacytidine

4. The spread of HIV-1 in Africa: sexual contact patterns and the predicted demographic impact of AIDS

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Co-emulsified Alginate-Eudragit Nanoparticles: Potential Carriers for Localized and Time-defined Release of Tenofovir in the Female Genital Tract;AAPS PharmSciTech;2024-01-10

2. Enhancement of bioavailability of therapeutics using drug conjugation approach: an in-depth review;International Journal of Polymeric Materials and Polymeric Biomaterials;2023-08-10

3. Exploring Nanotechnology as a Strategy to Circumvent Antimicrobial Resistance in Bone and Joint Infections;ACS Omega;2023-04-27

4. Enabling oral delivery of antiviral drugs: Double emulsion carriers to improve the intestinal absorption of zanamivir;International Journal of Pharmaceutics;2022-12

5. Lipid-Based Nanocarriers for Neurological Disorders: A Review of the State-of-the-Art and Therapeutic Success to Date;Pharmaceutics;2022-04-11